Last Price
0.033
Today's Change
0.00 (0.00%)
Day's Change
0.032 - 0.034
Trading Volume
44,894,926
Market Cap
24 Million
Shares Outstanding
745 Million
Avg Volume
2,046,133
Avg Price (50 Days)
0.04
Avg Price (200 Days)
0.06
PE Ratio
-1.10
EPS
-0.03
Earnings Announcement
01-Nov-2024
Previous Close
0.03
Open
0.03
Day's Range
0.032 - 0.034
Year Range
0.028 - 0.11
Trading Volume
44,894,926
1 Day Change
0.00%
5 Day Change
-8.33%
1 Month Change
-9.82%
3 Month Change
6.57%
6 Month Change
-48.28%
Ytd Change
-56.00%
1 Year Change
-64.83%
3 Year Change
-96.73%
5 Year Change
-97.30%
10 Year Change
-97.30%
Max Change
-97.30%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.